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Abstract Purpose: Infections
after pediatric cardiac surgery are a
common complication, occurring in
up to 30% of cases. The purpose of
this study was to develop a bedside
prediction rule to estimate the risk of
a postoperative infection. Meth-
ods: All consecutive pediatric
cardiac surgery procedures between
April 2006 and May 2009 were ret-
rospectively analyzed. The primary
outcome variable was any postopera-
tive infection, as deﬁned by the
Center of Disease Control (2008). All
variables known to the clinician at the
bedside at 48 h post cardiac surgery
were included in the primary analysis,
and multivariable logistic regression
was used to construct a prediction
rule. Results: A total of 412 proce-
dures were included, of which 102
(25%) were followed by an infection.
Most infections were surgical site
infections (26% of all infections) and
bloodstream infections (25%). Three
variables proved to be most predictive
of an infection: age less than
6 months, postoperative pediatric
intensive care unit (PICU) stay longer
than 48 h, and open sternum for
longer than 48 h. Translation into
prediction rule points yielded 1, 4,
and 1 point for each variable,
respectively. Patients with a score of
0 had 6.6% risk of an infection,
whereas those with a maximal score
of 6 had a risk of 57%. The area under
the receiver operating characteristic
curve was 0.78 (95% conﬁdence
interval 0.72–0.83). Conclusions: A
simple bedside prediction rule
designed for use at 48 h post cardiac
surgery can discriminate between
children at high and low risk for a
subsequent infection.
Keywords Pediatric intensive care
unit  Infections  Cardiopulmonary
bypass  Prediction rule
Introduction
Infections occurring after pediatric cardiac surgery are a
frequent complication, with the reported incidence vary-
ing widely from 16 to 31% [1–4]. These infections are an
important burden in the recovery after surgery, as they
cause signiﬁcant morbidity and lengthen pediatric inten-
sive care unit (PICU) and total hospital stays [5].
The incidence of postoperative infections in children
after cardiac surgery is higher than may be expected in the
general PICU population (6–15%) [5–7]. This is pre-
sumed to be due to the hypoinﬂammatory phase of the
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The most common types of infections are those occurring
at the surgical site and bloodstream infections [1–4].
Perioperative risk factors have been identiﬁed previously,
yielding younger age at surgery, higher surgical com-
plexity, longer surgical and cardiopulmonary bypass
(CPB) duration, a longer PICU stay, and delayed sternal
closure as important risk factors [1–4, 9–15]. Although
these factors have helped to unravel the etiology of the
infections, they do not necessarily reliably determine
those patients which are most at risk. This creates the
need for a prediction model, which aims to assist the
clinician in the decision-making process. In the case of
postoperative infections, the question is which preventive
measures need to be taken, and in which patients?
In this study we used retrospective data from a recent
pediatric cardiac surgery cohort from our center in order
to identify which variables are predictive of postoperative
infections. The aim was to develop a prediction rule to
estimate the risk of an infection during hospital stay. The
rule was designed for use at 48 h postoperatively, as the
current protocol at our center is to stop prophylactic
antibiotics at this time.
Methods
Patient population
In this retrospective study we included all consecutive
cardiac surgery procedures performed with CPB in
patients under the age of 18 years, between April 2006
and May 2009 at the Wilhelmina Children’s Hospital,
University Medical Center Utrecht, the Netherlands. The
Wilhelmina Children’s Hospital is a university teaching
hospital with a level III PICU, and is one of the four
pediatric heart centers in the Netherlands. Patients were
excluded if they died during or within 48 h after surgery,
if charts were incomplete, or if long-term broad-spectrum
antibiotics were already started preoperatively because of
bloodstream infections. All data were collected by retro-
spective chart review using standardized case report
forms. The local institutional medical ethics committee
approved the study and waived the need for consent.
All patients received perioperative antibiotic prophy-
laxis, consisting of cefazolin 100 mg/kg a day, starting at
the induction of anesthesia and continued until 48 h
postoperatively or until sternal closure. A single dose of
dexamethasone (1 mg/kg) was administered to all patients
at the induction of anesthesia. Preoperative disinfection of
the skin of the thorax was performed with chlorhexidine
solution 0.5% in 70% alcohol. After correction of the
heart defect and directly before skin closure, disinfection
of the skin and wound margins was repeated with
chlorhexidine solution 0.5% in 70% alcohol. During the
study period no speciﬁc Staphylococcus aureus eradica-
tion protocols were performed. All procedures were
performed by the same surgical and anesthesiology team,
the latter being responsible for care in the operating room
as well as at the PICU.
Clinical variables
All known risk factors for postoperative infection from
the literature were considered for use in the prediction
model. However, only those readily available at the
bedside were included in the analyses, and these were
subsequently dichotomized (into a yes/no variable) using
accepted thresholds from the literature. The eligible
variables were age less than 6 months [2, 4, 9–11, 13, 14,
16]; preoperative admission at the PICU [3, 4, 9, 10, 13,
16]; surgical complexity [2–4, 10, 15]; previous cardiac
surgery with the use of CPB [3, 4, 10, 14]; duration of
surgery (timed from ﬁrst incision until closure) greater
than 3 h [9, 14]; CPB duration greater than 2 h [2, 3, 9,
14, 17, 18]; lowest nasopharyngeal temperature less than
25C[ 16, 19, 20]; use of inotropes [2, 11, 13], endotra-
cheal tube [5, 11, 13, 14], open sternum, and
rethoracotomy [2, 3, 5, 12, 14, 16]; PICU stay longer than
48 h postoperatively [2, 3, 5, 6, 11, 13]; red blood cell
transfusion (total of intra- and postoperative transfusion)
greater than 50 mL/kg [3, 11, 14, 16, 17]; and peak glu-
cose greater than 10 mmol/L in the ﬁrst 24 h
postoperatively [21, 22]. Surgical complexity was the
only variable to be categorized into three groups, which
was a simpliﬁed version of the RACHS-1 and Aristotle
score [23, 24]. The ‘low complexity’ group (reference
group) consisted of atrial and/or ventricular septal defect
closures with or without ductus arteriosus ligation; the
‘high complexity’ group comprised all neonatal proce-
dures resulting in a functionally univentricular heart. All
other procedures were classiﬁed as ‘medium complexity’.
Outcome deﬁnition
The primary outcome of this study consisted of all
infections presenting between 48 h after surgery until
discharge from hospital. The occurrence of a postopera-
tive infection was deﬁned by the criteria of the Centre of
Disease Control (CDC), revised by Horan et al. in 2008
[25]. If the origin or presence of an infection was not clear
during chart review, the case was presented to an expert
panel of two pediatric intensivists (NJGJ and AJvV)
blinded to patient name and potentially predictive vari-
ables. When pneumonia was considered, chest X-rays
were assessed by a pediatric radiologist (MG), similarly
blinded. If there was consensus that a patient had an
apparent infection, but insufﬁcient data were available to
classify the infection according to CDC criteria, it was
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stream infections include both conﬁrmed cases
(‘laboratory conﬁrmed’), and unconﬁrmed cases, where
clinical symptoms sufﬁce (‘clinical sepsis’), in accor-
dance with the CDC criteria. Also, bloodstream infections
were only classiﬁed as such when they were not related to
an infection at another site. Surgical site infections (SSI)
were categorized into incisional SSI or organ/space SSI.
Incisional SSI consist of superﬁcial and deep incisional
SSI, where the superﬁcial incisional SSI involve only skin
and subcutaneous tissue, and the deep incisional SSI
involve deep soft tissues (i.e., fascial and muscle layers).
Because of the difﬁculty of retrospective assignment of
tissue layers, these were combined into one category
(incisional SSI). Organ/space SSI are deﬁned as infections
occurring in organs or spaces which are opened during the
procedure, excluding skin, fascia, and muscle (e.g.,
mediastinitis, pleuritis). Microbiologic and virology data
were collected from charts and the hospital database.
Proven infections were deﬁned as infections conﬁrmed
either by culture or polymerase chain reaction (PCR), and
these infections were used as secondary outcome.
Statistical analysis
All variables were assessed for their association with
infections using two-sided Pearson chi-square or Fisher’s
exact tests, as appropriate. For missing data, imputation
techniques were used as complete case analysis would
probablyintroducebias[26].Apvaluelessthan0.15inthe
univariable analysis allowed the variable to be used in the
multivariable logistic regression model, providing it was
not colinear with other variables (Pearson correlation
greater than 0.7). Manual stepwise backward logistic
regression was then performed. The choice for the ﬁnal
modelwasbasedonabalancebetweenahighareaunderthe
curve (AUC) and the clinical utility. The discriminative
potential of the ﬁnal model was assessed using the AUC of
the receiver operating characteristic (ROC) curve. A use-
less predictive model has an ROC-AUC of 0.5 and a
perfectly predictive model results in an ROC-AUC of 1.0.
The calibrative potential was assessed using the Hosmer–
Lemeshow test. The ﬁnal model was internally validated
using bootstrap techniques, which provide a ‘shrinkage
factor’ for the variable estimates. Alternative models that
includedmorevariableswerecomparedwiththeﬁnal,fully
reduced model. Furthermore, the robustness of the model
was tested by using the secondary outcome (proven infec-
tions)andbyrepeatingtheanalysisforcompletecasesonly.
The ﬁnal model was translated into a prediction rule,
yielding ‘rule points’ for each variable. Rule points were
calculated by dividing the multivariable regression coef-
ﬁcient by the lowest coefﬁcient and rounding to the
nearest integer. All patients were categorized according to
their scores and the corresponding positive and negative
predictive values were calculated. The calibration of the
model was assessed by calculating the predicted risks of
all cases belonging to one risk group.
Bootstrap techniques were performed with R for
Windows version 2.10.1 (R Foundation for Statistical
Computing, Vienna, Austria). SPSS version 15.0 (SPSS
Inc., Chicago, IL) was used for all other statistical
analyses.
Results
A total of 426 procedures were performed in the inclusion
period, of which 412 procedures performed in 364
patients remained for analysis (with incomplete ﬁles in
three procedures, four patients who already had long-term
antibiotics started preoperatively, and seven patients who
died within 48 h postoperatively). Patient characteristics
are outlined in Table 1.
Postoperative infections occurred after 102 proce-
dures, yielding an incidence of 25% (95% conﬁdence
interval [CI] 21–29). The total number of infections was
127, with 81 procedures being followed by a single
infection, 17 procedures by two, and four procedures by
three infections. The median start of infection was 7 days
after surgery (interquartile range [IQR] 4–12).
Of all infections, 72 (57%) were proven by culture or
PCR, with seven cases yielding two different microor-
ganisms (Table 2). The two most common types of
infection were SSI, responsible for 33 (26%) of all infec-
tions,andbloodstreaminfections,responsiblefor32(25%)
of all infections. SSI were mostly incisional SSI (n = 24,
consisting of both superﬁcial and deep incisional SSI), and
nine organ/space SSI (mediastinitis in ﬁve cases, and
pleuritis in four cases) (Table 2). Most SSI were caused by
S. aureus (71% of all proven infections), whereas in
bloodstream infections, coagulase-negative Staphylococ-
cus was most abundant (44%). In urinary tract infections,
Escherichia coli was isolated most often (33%).
Differences between the group with versus without
infections regarding various perioperative risk factors for
infections are shown in Table 3. After screening for
colinearity, where surgery and CPB duration were colin-
ear, as well as inotrope and endotracheal tube duration
and PICU stay, nine variables were ﬁnally included in the
multivariable analysis. Following backward logistic
regression, three variables remained in the ﬁnal prediction
model, which were age less than 6 months, PICU stay
longer than 48 h, and open sternum for longer than 48 h.
This model had an AUC-ROC of 0.78 (95% CI
0.73–0.83) with an acceptable Hosmer–Lemeshow
goodness of ﬁt of p = 0.60.
Bootstrapping resulted in a shrinkage factor of 88%,
suggesting some overﬁtting of the model. Addition of
other clinical variables, yielded similar ROC-AUCs (e.g.,
476with addition of surgical complexity, the ROC-AUC
remained identical). A complete cases analysis also
resulted in the same predictive variables and ROC-AUC.
Finally, when proven infections only were used, the ﬁnal
model was similar but with a somewhat reduced ROC-
AUC of 0.72 (95% CI 0.65–0.79).
To develop the prediction rule, rule points were
derived from the regression coefﬁcients of the three ﬁnal
variables as shown in Table 4. One point was counted if
the child was less than 6 months of age at surgery, 4
points if the child had a PICU stay longer than 48 h, and
1 point if the sternum was open for longer than 48 h. For
example, a child aged 6 years, already discharged from
the PICU, and with a closed sternum will have score of
0, and thus an infection risk of 6.6%. In contrast, a
neonate, still at the PICU at 48 h and with an open
sternum at that time (maximal score of 6) will have a risk
of 57%. Negative and positive predictive values for dif-
ferent cutoff values are shown in Table 5. This shows
that when a maximum number of rule points (6) is
reached, the positive predictive value is 57.4%; hence,
57% of children with score 6 will likely encounter an
infection, whereas 80% of all other children (score 5 or
lower) will not become infected. In contrast, out of all
children with a score of 1 or higher, 37% will encounter
an infection, whereas 93% of all children not belonging
to this category (so with a score of 0) will not become
infected. Observed and predicted infection rates for all
categories are depicted in Fig. 1, where predicted infec-
tion risks are calculated for each category using the
prediction rule.
Discussion
This study conﬁrms that infections remain a common
complication in children recovering from cardiac surgery.
We propose a novel bedside scoring system to assess the
risk of a postoperative infection in children following
Table 1 Patient characteristics
All procedures
(n = 412)
Procedures without
infection (n = 310)
Procedures with
infection (n = 102)
Male 226 (55) 167 (54) 59 (58)
Age (months) 6.8 (1.7–44) 11.3 (3.0–68) 3.2 (0.5–9.2)
Weight (kg) 6.7 (4.1–15) 8.5 (4.6–17.6) 4.6 (3.5–7.1)
Postoperative PICU stay (days) 2 (1–6) 2 (1–4) 7 (3–14)
Postoperative hospital stay (days) 7 (5–14) 6 (5–9) 20 (13–30)
Surgical complexity
a 8.0 (6.5–10.0) 8.0 (6.0–9.0) 9.0 (7.0–11.5)
Values stated as n (% of [infection] group) or median (interquartile range)
a Surgical complexity was calculated using the Aristotle score [24]
Table 2 Infection types and isolated microorganisms
Infection type
(CDC criteria)
n (% of
all infections)
Gram-positive
bacteria
Gram-negative
bacteria
Viruses Fungi/
yeasts
Microorganism
unknown
Surgical site infection 33 (25.9)
Incisional 24 4 1 0 0 19
Organ/space
a 963 0 0 0
Bloodstream infection 32 (25.1)
Laboratory conﬁrmed 16 12 4 0 0 0
Clinical sepsis 16 0 0 0 0 16
Urinary tract infection 15 (11.8)
Symptomatic 12 0 12 0 0 0
Asymptomatic 3 0 3 0 0 0
Gastroenteritis 18 (14.2) 0 0 10 0 8
Skin infection 6 (4.7) 1 0 0 2 3
Pneumonia
b 3 (2.4) 0 3 1 0 0
Respiratory tract infection 9 (7.1)
Upper 7 0 0 3 0 4
Lower 2 0 1 1 0 0
Other infections
c 11 (8.7) 3 2 0 1 5
Total (% of all infections) 127 26 (20.5) 29 (22.8) 15 (11.8) 3 (2.4) 55 (43.3)
a Mediastinitis (n = 5) and pleuritis (n = 4)
b In one pneumonia case, both Moraxella catarrhalis and Rhino-
virus were isolated
c Other infections: conjunctivitis (n = 3), oral cavity infection
(n = 3), decubitus (n = 1), endocarditis (n = 1), epididymitis
(n = 1), infection not otherwise speciﬁed (n = 2)
477cardiac surgery. Using three variables, namely age less
than 6 months, postoperative PICU stay longer than 48 h,
and open sternum for longer than 48 h, patients at high
risk of developing an infection can be distinguished from
those at low risk.
Recently, Barker and colleagues [10] similarly
developed a prediction rule, designed for clinical use. The
model included the variables age, complexity, genetic
abnormality, previous cardiac surgery, preoperative
length of stay, and preoperative ventilator support.
Although their model predicted as well as our study
(ROC-AUC of 0.78), variables such as genetic abnor-
mality and surgical complexity are not ideal in a bedside
prediction rule, as the former has often not yet been
conﬁrmed preoperatively, and the latter demands a search
through the extensive lists of Aristotle and RACHS-1
complexity scores. In addition, as the authors point out,
many of the infection cases were diagnosed without the
use of predeﬁned speciﬁc criteria.
The current prediction rule is based on three simple
variables: the age of the patient, PICU stay longer than
48 h, and an open sternum for longer than 48 h. Other
Table 3 Univariable analysis of procedures without and with postoperative infection
Procedures without
infection (n = 310)
Procedures with
infection (n = 102)
OR (95% CI) p
c
Preoperative
Age\6 months
a 123 (40) 73 (72) 3.83 (2.35–6.23) \0.001
Preoperative admission PICU
a 49 (16) 44 (43) 4.04 (2.46–6.64) \0.001
Low complexity
a 68 (22) 10 (9.8) 1.0 \0.001
Medium complexity
a 228 (74) 74 (73) 2.21 (1.08–4.51)
High complexity
a 14 (4.5) 18 (18) 8.74 (3.34–23)
Previous cardiac surgery 115 (37) 21 (20) 0.74 (0.46–1.20) 0.24
Intraoperative
Surgery duration[3 h 147 (47) 67 (66) 2.12 (1.33–3.38) 0.001
CPB duration[2h
a 114 (37) 58 (57) 2.27 (1.44–3.57) \0.001
Lowest nasal temp\25C
a 80 (26) 49 (48) 2.66 (1.67–4.23) \0.001
Postoperative
Inotropes[48 h 83 (27) 69 (68) 5.72 (3.52–9.29) \0.001
Endotracheal tube[48 h 66 (21) 61 (60) 5.50 (3.40–8.89) \0.001
PICU stay[48 h
a 105 (34) 84 (82) 9.11 (5.20–16) \0.001
Open sternum at 48 h
a 23 (7.4) 30 (29) 5.20 (2.85–9.49) \0.001
Rethoracotomy 9 (2.9) 3 (2.9) 1.01 (0.27–3.82) [0.999
RBC transfusion[50 mL/kg
a,b 142 (46) 83 (81) 5.17 (2.99–8.92) \0.001
Peak glucose[10 mmol/L in ﬁrst 24 h
a 151 (49) 65 (64) 1.85 (1.17–2.93) 0.009
Variables stated as n (% of infection group)
RBC red blood cell
a These variables were used in multivariable analysis
b Seven patients had missing data for RBC transfusion and were
imputed resulting in the above values
c p values were calculated using Pearson chi-square or Fisher’s
exact test, as appropriate
Table 4 Multivariable analysis and derivation of prediction rule points
Univariable
OR (95% CI)
Multivariable
OR (95% CI)
p Multivariable B Points
for rule
Age\6 months 3.83 (2.35–6.23) 1.53 (0.86–2.72) 0.15 0.44 1
PICU stay[48 h 9.11 (5.20–16) 6.30 (3.35–12) \0.001 1.84 4
Open sternum[48 h 5.20 (2.85–9.49) 1.83 (0.95–3.51) 0.07 0.60 1
Total 6
OR odds ratio, B regression coefﬁcient
Table 5 Performance of various cutoffs for rule points
Number of
rule points
n True positive
(n = 102)
Positive predictive
value (%)
n (not in
rule points)
True negative
(n = 310)
Negative
predictive value (%)
C1 245 91 37.1 167 156 93.4
C4 189 84 44.4 223 205 91.9
C5 146 69 47.3 266 233 87.6
6 47 27 57.4 365 290 79.5
478studies have also shown that these are important risk
factors for postoperative infections. Neonates and young
infants are known to have an immature immune system
lacking a proper innate immune response, likely respon-
sible for the higher rate of infections in this group [2–4, 9,
11, 27]. Prolonged admittance (more than 48 h) at the
PICU is commonly associated with longer duration of
mechanical ventilation and increased use of intravascular
catheters [3, 5, 9, 11]. Furthermore, delayed sternal clo-
sure has not only been associated with a higher risk of
SSI, but also with an increased occurrence of bloodstream
infections [12]. As these two infection types make up the
majority of the infections found in this study, this
emphasizes the importance of the open sternum as a risk
factor.
As our results show, the incidence of postoperative
infections remains high. This may be due to the inclusion
of all infections, as deﬁned by the CDC criteria (revised in
2008), where not all infections require a positive culture or
PCR [15]. Comparing the speciﬁc infection incidences to
those in the literature, SSI occurred after 6.4% of all
procedures in this study, whereas this varies 0.0–9.9% in
recent reports [1–4, 9, 13, 27]. Regarding bloodstream
infections, these also occurred after 6.4% of all procedures
in our study, of which half were proven by cultures and the
other half deﬁned as ‘clinical sepsis’. Recent reported
incidences vary from 2.6 to 15%, where comparison of
incidences is again difﬁcult due to different criteria [1–4,
10]. The isolated pathogens in SSI are in accordance with
the reports in the literature, as S. aureus was the most
commonly found pathogen in our study [13, 14]. Simi-
larly, bloodstream infections are most often caused by
gram-positive species, which our study conﬁrms [28].
Regarding the clinical application of our prediction
rule, various options may be possible. Firstly, the rule
may be used to determine those patients that are at the
highest risk of an infection, i.e., for use in a clinical trial
assessing the effectiveness of antimicrobial interventions.
Secondly, clinicians may wish to use the model to decide
on the routine antibiotic prophylaxis. As the most pre-
valent infections in our cohort were SSI and bloodstream
infections, mostly caused by gram-positive bacteria, and
with a median start of 1 week after surgery, a possibility
may be to prolong the cefazolin treatment in high-risk
groups. This may be prolonged for a set number of days,
or for example until drains and/or central lines have been
removed, as suggested in a recent study [29]. Overall,
improving compliance of personnel to hygiene measures
is likely one of the most important issues in infection
prevention.
However, a preventive strategy speciﬁcally directed at
one type of infection may be more effective. It was
recently shown in adults that preoperative screening and
eradication of S. aureus was an effective preventive
measure [30]. Since the end of our study, this has become
common practice in our hospital, the results of which
have to be evaluated in future. Another preventive strat-
egy against SSI is the continuation of prophylactic
antibiotics for 2–3 days after delayed sternal closure, with
or without routine culturing of the sternum, which may or
may not induce antimicrobial resistance [29, 31, 32].
Regarding bloodstream infections, the use of lines coated
with antibiotics, chlorhexidine wound dressings, routine
culturing of incision sites, or the continuation of antibi-
otics are all possible measures to consider [33, 34].
Limitations of this study mainly apply to issues of
heterogeneity in the infection cases. As we assessed all
types of postoperative infections, we cannot deﬁne which
risk factors speciﬁcally predict a surgical site infection, a
bloodstream infection, or an airway infection. This is due
to the size of our cohort, which restricts multivariable
analyses per subgroup. However, a (smaller) single-center
study usually does result in a more homogeneous group as
far as perioperative strategies are concerned. Also, all
data can be veriﬁed, which is crucial to the validity,
especially in a study focussed on infections. Another
limitation is that the prediction model has not been
externally validated. The speciﬁc perioperative manage-
ment at our hospital may differ from others, although our
infection cases are very similar to those in the literature.
Important characteristics of our perioperative manage-
ment are the choice of cefazolin as perioperative
prophylaxis and the use of dexamethasone during the
induction of anesthesia (which may or may not inﬂuence
susceptibility to infections [35, 36]). Finally, it is impor-
tant to note that the prediction rule proposed in this study
is based on categories of patients. Hence, the individual
patient, who may already clinically show signs of a local
infection, will likely have higher odds of infection than
the predicted ‘baseline’ risk stated in this paper. However,
aspeciﬁc clinical symptoms such as fever or a high
C-reactive protein level after cardiac surgery fail to
Fig. 1 Calibration of the prediction rule, with observed and
predicted infection risks. Score of 0 points, n = 167; score of 1
or 2 points (pooled), n = 56; score of 3 or 4 points (pooled),
n = 43; score of 5 points, n = 99 and score of 6 points, n = 47
479predict occurrence of an infection, which underlines the
need for a reliable prediction rule [37].
In conclusion, postoperative infections remain com-
mon in this recent cohort of children undergoing cardiac
surgery. Using important risk factors, we have developed
a bedside prediction rule which estimates the risk of a
subsequent infection during hospital stay. This tool may
prove useful for directing preventive measures to those
patients at the highest risk.
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